Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Alternative data sources for estimating multiple sclerosis prevalence.
[Difficulties experienced at work by patients with multiple sclerosis].
Preventive treatment with methylprednisolone paradoxically exacerbates experimental autoimmune encephalomyelitis.
Prediction of disability progression in fingolimod-treated patients.
[Charcot-Marie-Tooth disease associated with periaxin mutations (CMT4F): Clinical, electrophysiological and genetic analysis of 24 patients.]
Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes.
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study.
Clinically isolated syndrome manifested as acute vestibular syndrome: Bedside neuro-otological examination and suppression of transient evoked otoacoustic emissions in the differential diagnosis.
Industry Update: The latest developments in therapeutic delivery.
Multiple sclerosis: individualized disease susceptibility and therapy response.
Pragmatic exercise intervention for people with multiple sclerosis (ExIMS Trial): Study protocol for a randomised controlled trial.
Protein kinase C polymorphisms and vitamin D levels in multiple sclerosis.
Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.
Alterations of juxtaparanodal domains in two rodent models of CNS demyelination.
Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients.
Heterogeneity of acute multiple sclerosis lesions on sodium (23Na) MRI.
Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms.
Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal.
Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis.
Seronegative NMO: A sensitive AQP4 antibody test clarifies clinical features and next challenges.
Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.
Effects of single dose mixed amphetamine salts - extended release on processing speed in multiple sclerosis: a double blind placebo controlled study.
Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome.
Safety of TNF inhibitors in adolescents and children.
Subcutaneous IgG in neurologic diseases.
Pages
« first
‹ previous
…
386
387
388
389
390
391
392
393
394
…
next ›
last »